Compare Nerdwallet Inc (NRDS) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nerdwallet Inc vs Nuwellis Inc — how do they compare? Nerdwallet Inc trades at $9.22 (market cap $603.70M), while Nuwellis Inc trades at $2.94 (market cap $1.09M). The key difference: Nerdwallet Inc is far larger — about 553.9× Nuwellis Inc's market cap, and Nerdwallet Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NRDS | NUWE | |
|---|---|---|
Market Cap | $603.70M | $1.09M |
Sector | Financials | Technology |
52-Week High | $15.93 | $527.46 |
52-Week Low | $7.58 | $2.80 |
Enterprise Value | $518.00M | -$722.58K |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NRDS trades at $9.12, down 1.51% today, with a bearish technical signal but strong fundamentals including a 93% gross margin and consistent earnings beats. Revenue grew to $836.6M in 2025, with net income reaching $48.7M. Positive analyst sentiment includes a $12.75 consensus target, though technical indicators show near-term pressure.
The stock offers value with a P/E of 9.87 and upside potential from analyst targets, but faces risks from competitive pressures and reliance on consumer financial health. Earnings growth and margin expansion are key catalysts, yet macroeconomic sensitivity could impact performance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nerdwallet Inc
Nerdwallet Inc is a free tool to find you the best credit cards, cd rates, savings, checking accounts, scholarships, healthcare and airlines.
Read more on NRDS →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
